Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Chimeric autoantibody receptor T cells for targeted depletion of myeloperoxidase-specific anti-neutrophil cytoplasmic antibody-producing B cells.

Frontiers in immunology·2026

Same author

Empagliflozin and Ultrafiltration Volume in Patients Undergoing Peritoneal Dialysis.

Kidney international reports·2026

Same author

Treatment of atypical hemolytic uremic syndrome and C3 glomerulopathy in mice by hepatic expression of factor D.

Blood advances·2026

Same author

A spatial atlas of the complement system uncovers unique expression patterns in postnatal brain development in mice.

Nature communications·2025

Same author

Domain-adaptive semi-supervised learning for efficient rare pathological lesion detection with minimal annotation.

NPJ digital medicine·2025

Same author

Staged Thumb Reconstruction Via Primary Ectopic Banking of Detached Skeletal Elements and Amputated Thumbs With Secondary Replantation.

The Journal of craniofacial surgery·2025

Same journal

ST2-mediated ERK/JNK/P38/NF-κB signaling: a target of Biminkang mixture in minimal persistent inflammation of allergic rhinitis.

Immunobiology·2026

Same journal

Chronic stress promotes colorectal cancer progression by inducing M2 macrophage polarization and activating the CCL2-CCR2 axis.

Immunobiology·2026

Same journal

Spatial-cellular resolution analysis of ferroptosis-associated immune microenvironment heterogeneity in osteoarthritic cartilage.

Immunobiology·2026

Same journal

Exploring therapeutic targets for neuroinflammation in sepsis-associated encephalopathy: a combined network pharmacology and bioinformatics approach.

Immunobiology·2026

Same journal

Potential correlation assessment identified by a genome-wide association study using induced pluripotent stem cells from patients with IgAN.

Immunobiology·2026

Same journal

MicroRNA-5011-5p attenuates LPS-induced inflammatory damage in periodontal ligament cells by targeting KLF6: an in vitro study.

Immunobiology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 18, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Modeling complement-driven diseases in transgenic mice: Values and limitations.

Yoshiyasu Ueda¹, Damodar Gullipalli¹, Wen-Chao Song¹

¹Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States.

|July 4, 2016

Summary

This summary is machine-generated.

Transgenic animal models advance understanding of complement-mediated diseases like PNH, aHUS, and C3G. While valuable for therapy development, species differences in complement systems present limitations.

Keywords:

C3G Complement PNH Transgenic mouse aHUS

More Related Videos

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Related Experiment Videos

Last Updated: Mar 18, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Area of Science:

Immunology
Genetics
Nephrology

Background:

Significant progress in understanding complement-mediated diseases.
Development of novel therapies and re-classification of complement-driven conditions.
Human patient insights and transgenic animal models have driven these advances.

Purpose of the Study:

To review transgenic animal models for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and C3 glomerulopathy (C3G).
To highlight the utility and constraints of animal models in complement-driven disease research.
To exemplify the role of animal models in anti-complement therapy development.

Main Methods:

Review of existing literature on transgenic animal models for PNH, aHUS, and C3G.
Analysis of the value and limitations of these models in studying complement pathways.
Focus on diseases at the forefront of anti-complement therapeutic strategies.

Main Results:

Transgenic animal models offer crucial insights into disease mechanisms.
Species-specific differences in complement systems pose challenges for direct translation.
These models are instrumental in evaluating new anti-complement therapies.

Conclusions:

Transgenic animal models are indispensable tools for studying complement-mediated diseases.
Careful consideration of species differences is essential for accurate interpretation of model data.
Animal models significantly contribute to the advancement of anti-complement therapies for PNH, aHUS, and C3G.